Carmine J. Durham

Chief Strategy Officer at Cage Bio

Carmine is an industry veteran with 30+ years experience in pharma and med tech operations. He has held senior positions at Knoll/BASF Pharma, Abbott Laboratories, and was the VP of Corporate Development at BoneCare Int’l., sold to Genzyme (now Sanofi) for $660M. As a Co-Founder and former CEO of Zurex Pharma, Carmine has experience raising millions in equity and debt financings, and successfully executed several strategic transactions.


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Cage Bio

Cage Bio develops novel products for dermatology, inflammation, and immunology.


Employees

1-10

Links